Temporary supply shortage for Adenoscan® (adenosine injection)


There is currently a temporary supply shortage for Adenoscan® (adenosine injection), which is produced by Astellas Pharma. This situation is expected to be resolved by the first quarter of 2013. Astellas is not withdrawing or recalling Adenoscan from the market. This shortage is due to unanticipated demand. Please contact the Astellas Medical Communications Department at 800-727-7003 if you have any medical questions. Your distributor may still have product available -- please contact your supplier for updated information. While this shortage exists, regadenoson or dipyridamole may be considered as alternative agents. For usage information, please view ASNC's Imaging Guidelines for Stress Protocols.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC